Clinical Trial Update: Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating atezolizumab in combination with paclitaxel, trastuzumab, and pertuzumab for metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING